Medically refractory epilepsy remains a significant clinical challenge, affecting approximately 30 percent of the 3.4 million Americans living with epilepsy.
The FDA has approved Khindivi, the first hydrocortisone oral solution for pediatric adrenal insufficiency, offering precise, ready-to-use dosing for patients aged 5 years and older.
Almost half of surgeons miss exercise guidelines, but research shows "weekend warriors" achieve similar cardiovascular benefits to those who exercise daily.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Innovations in craniosynostosis management and cranial vault remodeling have improved diagnosis, preoperative planning and treatment resulting in improved patient outcomes and more personalized care...
A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.